BCR-ABL1 kinase domain mutational analysis of CD34+ stem/progenitor cells in newly diagnosed CML patients by next-generation sequencing

Am J Hematol. 2014 Oct;89(10):1016-7. doi: 10.1002/ajh.23794. Epub 2014 Jul 22.

Authors

Milena Musilova¹, Filip Razga, Tomas Jurcek, Ivana Jeziskova, Marek Borsky, Veronika Nemethova, Daniela Zackova, Martin Culen, Dana Dvorakova, Jiri Mayer, Zdenek Racil

Affiliation

¹ Department of Internal Medicine, Hematology and Oncology, Faculty of Medicine, Masaryk University and University Hospital Brno, Brno, Czech Republic.

PMID: 24984979
DOI: 10.1002/ajh.23794

No abstract available

Publication types

Letter

MeSH terms

Antigens, CD34*
DNA Mutational Analysis / methods
Female
Fusion Proteins, bcr-abl / genetics*
Humans
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / genetics*
Male
Protein Structure, Tertiary
Stem Cells*

Substances

Antigens, CD34
BCR-ABL1 fusion protein, human
Fusion Proteins, bcr-abl